Connect Biopharma Holdings (CNTB) Non Operating Income (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Non Operating Income of $257000.0 for Q1 2026, down 42.12% sequentially from $444000.0 in Q4 2025, and down 79.09% YoY from $1.2 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Non Operating Income (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Non Operating Income for 3 years, with the latest figure at $257000.0 in Q1 2026.
- Quarterly Non Operating Income fell 79.09% year-over-year to $257000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 57.76% YoY) and the FY2025 annual result came in at $2.8 million, down 60.39% from the prior year.
- Non Operating Income retreated to $257000.0 in Q1 2026 per CNTB's latest filing, from $444000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $4.0 million in Q1 2024 and troughed at $257000.0 in Q1 2026.
- A 3-year average of $1.1 million and a median of $819000.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income plunged 45.79% in 2025, then slumped 79.09% in 2026.
- Over 3 years, Non Operating Income stood at $819000.0 in 2024, then slumped by 45.79% to $444000.0 in 2025, then tumbled by 42.12% to $257000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $257000.0, $444000.0, and $538000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 380,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 380,000.00 |
| Mar 31, 2026 | 257,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | 580,000.00 |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 819,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 3.97 Mn |